Girdhari Roy

@bits-pilani.ac.in

PhD Student
Department of Pharmacy, BITS PIlani, Hyderabad Campus, India

Girdhari Roy


                  Download Compact PDF  
https://researchid.co/girdhariroy
Currently, I am working on ocular drug delivery using polymeric microneedle

EDUCATION

PhD Student

RESEARCH INTERESTS

Novel Drug Delivery System, Ocular Drug Delivery, Pharmacokinetics, Bioanalysis
395

Scholar Citations

7

Scholar h-index

7

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

  • Ocular delivery of cyclosporine A using dissolvable microneedle contact lens
    D Datta, G Roy, P Garg, VVK Venuganti
    Journal of Drug Delivery Science and Technology 70, 103211 , 2022
    2022
    Citations: 65
  • Transfersome hydrogel containing 5-fluorouracil and etodolac combination for synergistic oral cancer treatment
    SR Bollareddy, V Krishna, G Roy, D Dasari, A Dhar, VVK Venuganti
    AAPS PharmSciTech 23 (2), 70 , 2022
    2022
    Citations: 23
  • Microneedle scleral patch for minimally invasive delivery of triamcinolone to the posterior segment of eye
    G Roy, P Garg, VVK Venuganti
    International Journal of Pharmaceutics 612, 121305 , 2022
    2022
    Citations: 65
  • Ocular Delivery of Therapeutics Using Polymeric Microneedles
    G ROY
    2021
  • Microneedle ocular patch: fabrication, characterization, and ex-vivo evaluation using pilocarpine as model drug
    G Roy, RD Galigama, VS Thorat, P Garg, VVK Venuganti
    Drug development and industrial pharmacy 46 (7), 1114-1122 , 2020
    2020
    Citations: 74
  • Microprojection Ocular Patch Containing Amphotericin B Liposomes for Effective Treatment of Fungal Keratitis
    P Garg, V Venuganti, G Roy
    2020 World Cornea Congress , 2020
    2020
  • Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis
    G Roy, RD Galigama, VS Thorat, LS Mallela, S Roy, P Garg, ...
    International journal of pharmaceutics 572, 118808 , 2019
    2019
    Citations: 114
  • Novel drug delivery methods for the treatment of keratitis: moving away from surgical intervention
    P Garg, VVK Venuganti, A Roy, G Roy
    Expert opinion on drug delivery , 2019
    2019
    Citations: 26
  • Dissolvable microneedle-mediated transcutaneous delivery of tetanus toxoid elicits effective immune response
    SP Pattarabhiran, A Saju, KR Sonawane, R Manimaran, S Bhatnagar, ...
    Aaps PharmSciTech 20 (7), 257 , 2019
    2019
    Citations: 25
  • Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone
    AJ Fabrega, G Roy, L Reynolds, C Corwin, L Hunsicker
    Transplantation proceedings 30 (4), 1335-1336 , 1998
    1998
    Citations: 3
  • CYCLOSPORINE (CY) THERAPY IN ACTIVE HEYMANNS NEPHRITIS (AHN)-SUPPORT FOR THE DUAL ANTIBODY (AB) SYSTEM
    DC CATTRAN, G ROY, O ABRASS
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE 10 (4 … , 1987
    1987

MOST CITED SCHOLAR PUBLICATIONS

  • Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis
    G Roy, RD Galigama, VS Thorat, LS Mallela, S Roy, P Garg, ...
    International journal of pharmaceutics 572, 118808 , 2019
    2019
    Citations: 114
  • Microneedle ocular patch: fabrication, characterization, and ex-vivo evaluation using pilocarpine as model drug
    G Roy, RD Galigama, VS Thorat, P Garg, VVK Venuganti
    Drug development and industrial pharmacy 46 (7), 1114-1122 , 2020
    2020
    Citations: 74
  • Ocular delivery of cyclosporine A using dissolvable microneedle contact lens
    D Datta, G Roy, P Garg, VVK Venuganti
    Journal of Drug Delivery Science and Technology 70, 103211 , 2022
    2022
    Citations: 65
  • Microneedle scleral patch for minimally invasive delivery of triamcinolone to the posterior segment of eye
    G Roy, P Garg, VVK Venuganti
    International Journal of Pharmaceutics 612, 121305 , 2022
    2022
    Citations: 65
  • Novel drug delivery methods for the treatment of keratitis: moving away from surgical intervention
    P Garg, VVK Venuganti, A Roy, G Roy
    Expert opinion on drug delivery , 2019
    2019
    Citations: 26
  • Dissolvable microneedle-mediated transcutaneous delivery of tetanus toxoid elicits effective immune response
    SP Pattarabhiran, A Saju, KR Sonawane, R Manimaran, S Bhatnagar, ...
    Aaps PharmSciTech 20 (7), 257 , 2019
    2019
    Citations: 25
  • Transfersome hydrogel containing 5-fluorouracil and etodolac combination for synergistic oral cancer treatment
    SR Bollareddy, V Krishna, G Roy, D Dasari, A Dhar, VVK Venuganti
    AAPS PharmSciTech 23 (2), 70 , 2022
    2022
    Citations: 23
  • Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone
    AJ Fabrega, G Roy, L Reynolds, C Corwin, L Hunsicker
    Transplantation proceedings 30 (4), 1335-1336 , 1998
    1998
    Citations: 3
  • Ocular Delivery of Therapeutics Using Polymeric Microneedles
    G ROY
    2021
  • Microprojection Ocular Patch Containing Amphotericin B Liposomes for Effective Treatment of Fungal Keratitis
    P Garg, V Venuganti, G Roy
    2020 World Cornea Congress , 2020
    2020
  • CYCLOSPORINE (CY) THERAPY IN ACTIVE HEYMANNS NEPHRITIS (AHN)-SUPPORT FOR THE DUAL ANTIBODY (AB) SYSTEM
    DC CATTRAN, G ROY, O ABRASS
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE 10 (4 … , 1987
    1987

Publications

1. Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis
2. Novel drug delivery methods for the treatment of keratitis: moving away from surgical intervention
3. Dissolvable Microneedle-Mediated Transcutaneous Delivery of Tetanus Toxoid Elicits Effective Immune Response

INDUSTRY EXPERIENCE

2 years of experience in the Drug Metabolism and Pharmacokinetics department at Aurigene Drug Discovery Technology Ltd, Hyderabad, India.